SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-014330
Filing Date
2024-04-11
Accepted
2024-04-11 16:30:42
Documents
18
Period of Report
2024-04-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 136891
2 ex4-1.htm EX-4.1 133972
3 ex10-1.htm EX-10.1 274167
4 ex10-2.htm EX-10.2 266417
5 ex10-3.htm EX-10.3 201867
6 ex10-4.htm EX-10.4 197167
  Complete submission text file 0001493152-24-014330.txt   1612732

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mgrx-20240405.xsd EX-101.SCH 3033
8 XBRL LABEL FILE mgrx-20240405_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE mgrx-20240405_pre.xml EX-101.PRE 22371
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3800
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

IRS No.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 24838869
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)